Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119937642 | 11993764 | 2 | F | 2013 | 20160718 | 20160203 | 20160720 | EXP | PHHY2016FR011569 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160720 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119937642 | 11993764 | 1 | PS | FEMARA | LETROZOLE | 1 | Unknown | 2.5 MG, QD (DAILY) | 20726 | 2.5 | MG | FILM-COATED TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
119937642 | 11993764 | 1 | Breast cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
119937642 | 11993764 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
119937642 | 11993764 | Bone pain | |
119937642 | 11993764 | Dizziness | |
119937642 | 11993764 | Hyperhidrosis | |
119937642 | 11993764 | Myalgia | |
119937642 | 11993764 | Pruritus |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
119937642 | 11993764 | 1 | 201306 | 0 |